Itraconazole Overview
What itraconazole is, why it is being repurposed in oncology, and where the evidence is strongest
Itraconazole is best known as an antifungal medicine, but it is now attracting significant interest as a repurposed anticancer drug. It is especially relevant because it appears to target several tumour-survival pathways at once while also having a long-established safety history from routine clinical use.
At a Glance
What it is: An antifungal medicine being repurposed for oncology
Why it matters: It inhibits Hedgehog signalling, angiogenesis, AKT / mTOR, Wnt / β-catenin, and multidrug-resistance pathways
Best-supported use today: Investigational adjunctive use alongside standard treatment
Strongest evidence: Early clinical signals in prostate cancer, NSCLC, basal cell carcinoma, ovarian cancer, and combination-retrospective settings
Main limitation: Most cancer evidence remains early-stage, retrospective, or non-definitive
Why itraconazole is studied in oncology
Itraconazole moved into oncology research because it appears to act on several key tumour pathways that are not part of its original antifungal purpose.
Research suggests itraconazole may:
inhibit the Hedgehog pathway
reduce tumour angiogenesis
suppress AKT / mTOR signalling
modulate Wnt / β-catenin activity
help reverse multidrug resistance
Clinical Positioning
Current evidence best supports itraconazole as an investigational repurposed adjunct, not as a replacement for standard cancer therapy.
Its strongest practical interest is in the overlap between:
pathway-driven tumour biology
repurposed-drug strategies
combination protocols with chemotherapy
angiogenesis-focused treatment logic
Evidence Quality Rating
3.5/5 — Moderate evidence with meaningful early clinical signals
This rating reflects broad mechanistic interest, multiple human studies, and real clinical-response signals, but also acknowledges that much of the oncology evidence remains early, small, or retrospective.
Where to Go Next
Key References
Repurposing itraconazole for the treatment of cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC6769799/
Repurposed itraconazole for use in the treatment of malignancies as a promising therapeutic strategy https://www.sciencedirect.com/science/article/abs/pii/S1043661821003328
Repurposing itraconazole as an anticancer agent https://pmc.ncbi.nlm.nih.gov/articles/PMC5536437/
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
Last updated
Was this helpful?